. 2022 Nov 17;11(2):953–962. doi: 10.1002/fsn3.3130

TABLE 4.

Effects of PM EOD‐1 on serum lipids

	Group	Baseline	4 weeks	8 weeks	12 weeks	ANCOVA
Triglyceride (mmol/L)	Placebo	1.77 ± 0.20	2.01 ± 0.31	1.72 ± 0.20	1.75 ± 0.23	0.890
Triglyceride (mmol/L)	EOD‐1	1.99 ± 0.25	2.00 ± 0.25	2.46 ± 0.57	1.83 ± 0.19	0.890
HDL‐cholesterol (mmol/L)	Placebo	1.59 ± 0.07	1.53 ± 0.09	1.61 ± 0.09	1.54 ± 0.08	0.916
HDL‐cholesterol (mmol/L)	EOD‐1	1.60 ± 0.10	1.56 ± 0.09	1.55 ± 0.09	1.54 ± 0.09	0.916
LDL‐cholesterol (mmol/L)	Placebo	3.94 ± 0.16	3.69 ± 0.16	3.84 ± 0.17	3.84 ± 0.18	0.320
LDL‐cholesterol (mmol/L)	EOD‐1	4.35 ± 0.23	4.18 ± 0.22	4.18 ± 0.25	4.34 ± 0.22	0.320
Total cholesterol (mmol/L)	Placebo	6.33 ± 0.20	6.04 ± 0.19	6.17 ± 0.20	6.05 ± 0.21	0.319
Total cholesterol (mmol/L)	EOD‐1	6.80 ± 0.23	6.54 ± 0.22	6.76 ± 0.24	6.62 ± 0.22	0.319

Note: Mean ± standard error (SE).